Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer

참고문헌 (116)

1. van der Pol, E., "Classification, functions, and clinical relevance of extracellular vesicles", Pharmacol. Rev, 64, pp.676~705 (2012)
2. Harding, C. V., "Exosomes : looking back three decades and into the future", J. Cell Biol, 200, pp.367~371 (2013)
3. Yuana, Y., "Extracellular vesicles in physiological and pathological conditions", Blood Rev, 27, pp.31~39 (2013)
4. Minciacchi, V. R., "Extracellular vesicles in cancer:exosomes, microvesicles and the emerging role of large oncosomes", Semin. Cell Dev. Biol, 40, pp.41~51 (2015)
5. Schorey, J. S., "Exosomes and other extracellular vesicles in host-pathogen interactions", EMBO Rep, 16, pp.24~43 (2015)
6. Kalluri, R., "The biology and function of exosomes in cancer", J. Clin. Invest, 126, pp.1208~1215 (2016)
7. Valadi, H., "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells", Nat. Cell. Biol, 9, pp.654~659 (2007)
8. Costa-Silva, B., "Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver", Nat. Cell. Biol, 17, pp.816~826 (2015)
9. Hoshino, A., "Tumour exosome integrins determine organotropic metastasis", Nature, 527, pp.329~335 (2015)
10. Tkach, M., "Communication by extracellular vesicles : where we are and where we need to go", Cell, 164, pp.1226~1232 (2016)
11. Gangoda, L., "Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic?", Proteomics, 15, pp.260~271 (2015)
12. Ohno, S., "Focus on extracellular vesicles: development of extracellular vesicle-based therapeutic systems", Int. J. Mol. Sci, 17, pp.172~ (2016)
13. Pitt, J. M., "Extracellular vesicles: masters of intercellular communication and potential clinical interventions", J. Clin. Invest, 126, pp.1139~1143 (2016)
14. Milane, L., "Exosome mediated communication within the tumor microenvironment", J. Control. Release, 219, pp.278~294 (2015)
15. Spugnini, E. P., "A Role of Tumor-Released Exosomes in Paracrine Dissemination and Metastasis", Int. J. Mol. Sci, 19, pp.3968~ (2018)
16. Namee, N. M., "Extracellular vesicles and anti-cancer drug resistance", Biochim. Biophys. Acta Rev. Cancer, 1870, pp.123~136 (2018)
17. Santos, J. C., "Exosome-mediated breast cancer chemoresistance via miR-155 transfer", Sci. Rep, 8, pp.829~ (2018)
18. O’Neill, C. P., "Role of extracellular vesicles(EVs)in cell stress response and resistance to cancer therapy", Cancers(Basel), 11, pp.136~ (2019)
19. Xie, F., "The role of exosomal PD-L1 in tumor progression and immunotherapy", Mol. Cancer, 18, pp.146~ (2019)
20. Tang, Y., "The biogenesis, biology, and clinical significance of exosomal PDL1in cancer", Front. Immunol, 11, pp.604~ (2020)
21. Chen, G., "Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response", Nature, 560, pp.382~386 (2018)
22. Poggio, M., "Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory", Cell, 177, pp.414~427.e413 (2019)
23. Ricklefs, F. L., "Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles", Sci. Adv, 4, pp.eaar2766~ (2018)
24. Chen, J., "GOLM1 exacerbates CD8(+) T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages", Signal Transduct. Target. Ther, 6, pp.397~ (2021)
25. Leary, N., "Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes", J. Extracell. Vesicles, 11, pp.e12197~ (2022)
26. Huotari, J., "Endosome maturation", EMBO J, 30, pp.3481~3500 (2011)
27. Henne, W. M., "Molecular mechanisms of the membrane sculpting ESCRT pathway", Cold Spring Harb. Perspect. Biol, 5, pp.a016766~ (2013)
28. Chiaruttini, N., "Relaxation of loaded ESCRT-III spiral springs drives membrane deformation", Cell, 163, pp.866~879 (2015)
29. Lee, I. H., "Negative membrane curvature catalyzes nucleation of endosomal sorting complex required for transport(ESCRT)-III assembly", Proc. Natl Acad. Sci. USA, 112, pp.15892~15897 (2015)
30. McCullough, J., "Structure and membrane remodeling activity of ESCRT-III helical polymers", Science, 350, pp.1548~1551 (2015)
31. Christ, L., "Cellular functions and molecular mechanisms of the ESCRT membrane-scission machinery", Trends Biochem. Sci, 42, pp.42~56 (2017)
32. Baietti, M. F., "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes", Nat. Cell Biol, 14, pp.677~685 (2012)
33. Friand, V., "Syntenin and syndecan in the biogenesis of exosomes", Biol. Cell, 107, pp.331~341 (2015)
34. Roucourt, B., "Heparanase activates the syndecan-syntenin-ALIX exosome pathway", Cell Res, 25, pp.412~428 (2015)
35. Pike, L. J., "Lipid rafts : bringing order to chaos", J. Lipid Res, 44, pp.655~667 (2003)
36. Trajkovic, K., "Ceramide triggers budding of exosome vesicles into multivesicular endosomes", Science, 319, pp.1244~1247 (2008)
37. Lingwood, D., "Lipid rafts as a membrane-organizing principle", Science, 327, pp.46~50 (2010)
38. Record, M., "Emerging concepts on the role of exosomes in lipid metabolic diseases", Biochimie, 96, pp.67~74 (2014)
39. Skotland, T., "Lipids in exosomes : current knowledge and the way forward", Prog. Lipid Res, 66, pp.30~41 (2017)
40. Ranganathan, S., "Effect of pantethine on the biosynthesis of cholesterol in human skin fibroblasts", Atherosclerosis, 44, pp.261~273 (1982)
41. Roseblade, A., "Targeting microparticle biogenesis : a novel approach to the circumvention of cancer multidrug resistance", Curr. Cancer Drug Targets, 15, pp.205~214 (2015)
42. Kavian, N., "Pantethine prevents murine systemic sclerosis through the inhibition of microparticle shedding", Arthritis Rheumatol, 67, pp.1881~1890 (2015)
43. Shamseddine, A. A., "Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes", Adv. Biol. Regul, 57, pp.24~41 (2015)
44. Panigrahi, G. K., "Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells", Sci. Rep, 8, pp.3853~ (2018)
45. Arenz, C., "Small molecule inhibitors of acid sphingomyelinase", Cell. Physiol. Biochem, 26, pp.1~8 (2010)
46. Bianco, F., "Acid sphingomyelinase activity triggers microparticle release from glial cells", EMBO J, 28, pp.1043~1054 (2009)
47. Kosgodage, U. S., "Chloramidine", bisindolylmaleimide-I-mediated inhibition of exosome and microvesicle release and enhanced efficacy of cancer chemotherapy, 2017, pp.18, 1007~
48. Li, J., "Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity", Nat. Immunol, 14, pp.793~803 (2013)
49. Figuera-Losada, M., "Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties", PLoS ONE, 10, pp.e0124481~ (2015)
50. Kulshreshtha, A., "Simvastatin mediates inhibition of exosome synthesis, localization and secretion via multicomponent interventions", Sci. Rep, 9, pp.16373~ (2019)
51. Nieland, T. J., "Cross-inhibition of SR-BI-and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide", J. Lipid Res, 45, pp.1256~1265 (2004)
52. Henriksson, C. E., "Anticoagulant effects of an antidiabetic drug on monocytes in vitro", Thromb. Res, 128, pp.e100~e106 (2011)
53. Aung, T., "Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3", Proc. Natl Acad. Sci. USA, 108, pp.15336~15341 (2011)
54. Koch, R., "Nuclear trapping through inhibition of exosomal export by indomethacin increases cytostatic efficacy of doxorubicin and pixantrone", Clin. Cancer Res, 22, pp.395~404 (2016)
55. Lowry, M. C., "The role of exosomes in breast cancer", Clin. Chem, 61, pp.1457~1465 (2015)
56. Martin, L. A., "The farnesyltransferase inhibitor R115777(tipifarnib)in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo", Mol. Cancer Ther, 6, pp.2458~2467 (2007)
57. McConnell, R. E., "The enterocyte microvillus is a vesicle-generating organelle", J. Cell Biol, 185, pp.1285~1298 (2009)
58. Li, B., "RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells", Oncogene, 31, pp.4740~4749 (2012)
59. van Niel, G., "Shedding light on the cell biology of extracellular vesicles", Nat. Rev. Mol. Cell Biol, 19, pp.213~228 (2018)
60. Li, M., "Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes", macrophages, 2010, pp.30, 1818~1824
61. Colombo, M., "Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles", Annu. Rev. Cell Dev. Biol, 30, pp.255~289 (2014)
62. Siklos, M., "Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors", Acta Pharm. Sin. B, 5, pp.506~519 (2015)
63. Stratton, D., "Prostate cancer cells stimulated by calcium-mediated activation of protein kinase C undergo a refractory period before re-releasing calcium-bearing microvesicles", Biochem. Biophys. Res. Commun, 460, pp.511~517 (2015)
64. Leloup, L., "Calpains as potential anti-cancer targets", Expert Opin. Ther. Targets, 15, pp.309~323 (2011)
65. Atanassoff, A. P., "Microvesicle shedding and lysosomal repair fulfill divergent cellular needs during the repair of streptolysin O-induced plasmalemmal damage", PLoS ONE, 9, pp.e89743~ (2014)
66. Jorfi, S., "Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo", Sci. Rep, 5, pp.13006~ (2015)
67. Sapet, C., "Thrombin-induced endothelial microparticle generation : identification of a novel pathway involving ROCK-II activation by caspase-2", Blood, 108, pp.1868~1876 (2006)
68. Datta, A., "Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras", Raf, 2 signaling and hnRNP H1 in castrationresistant prostate cancer cells, pp.Cancer Lett, 2017[DOI]
69. Zhou, X., "Exosome production and its regulation of EGFR during wound healing in renal tubular cells", Am. J. Physiol. Ren. Physiol, 312, pp.F963~F970 (2017)
70. Savina, A., "Exosome release is regulated by a calcium-dependent mechanism in K562 cells", J. Biol. Chem, 278, pp.20083~20090 (2003)
71. Chalmin, F., "Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells", J. Clin. Invest, 120, pp.457~471 (2010)
72. Datta, A., "High-throughput screening identified selective inhibitors of exosome biogenesis and secretion : a drug repurposing strategy for advanced cancer", Sci. Rep, 8, pp.8161~ (2018)
73. Haluska, P., "Farnesyl transferase inhibitors as anticancer agents", Eur. J. Cancer, 38, pp.1685~1700 (2002)
74. Sella, A., "Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer", J. Clin. Oncol, 12, pp.683~688 (1994)
75. Im, E. J., "Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A", Nat. Commun, 10, pp.1387~ (2019)
76. Lee, C. H., "Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1", Theranostics, 12, pp.1971~1987 (2022)
77. Hong, Y. L., "Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs", Antimicrob. Agents Chemother, 39, pp.1756~1763 (1995)
78. Mechoulam, R., "Cannabidiol: an overview of some pharmacological aspects", J. Clin. Pharm, 42, pp.11S~19S (2002)
79. Martin-Moreno, A. M., "Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease", Mol. Pharmacol, 79, pp.964~973 (2011)
80. Blessing, E. M., "Cannabidiol as a potential treatment for anxiety disorders", Neurotherapeutics, 12, pp.825~836 (2015)
81. Pisanti, S., "Cannabidiol : state of the art and new challenges for therapeutic applications", Pharmacol. Ther, 175, pp.133~150 (2017)
82. Kosgodage, U. S., "Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer", Front. Pharmacol, 9, pp.889~ (2018)
83. Kosgodage, U. S., "Cannabidiol affects extracellular vesicle release, miR21and miR126, and reduces prohibitin protein in glioblastoma multiforme cells", Transl. Oncol, 12, pp.513~522 (2019)
84. Franzius, D., "Non-specific effects of calcium entry antagonists in mast cells", Pflug. Arch, 428, pp.433~438 (1994)
85. Khan, F. M., "Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin", Cancer Biol. Ther, 19, pp.25~33 (2018)
86. Soboloff, J., "Sensitivity of myeloid leukemia cells to calcium influx blockade : application to bone marrow purging", Exp. Hematol, 30, pp.1219~1226 (2002)
87. 김현지, "Novel Suppressive Effects of Ketotifen on Migration and Invasion of MDA-MB-231 and HT-1080 Cancer Cells", Biomolecules & Therapeutics, 22(6), pp.540~546 (2014), 한국응용약물학회
88. Parolini, I., "Microenvironmental pH is a key factor for exosome traffic in tumor cells", J. Biol. Chem, 284, pp.34211~34222 (2009)
89. Logozzi, M., "Microenvironmental pH and exosome levels interplay in human cancer cell lines of different histotypes", Cancers, 10, pp.370~ (2018)
90. De Milito, A., "Tumor acidity, chemoresistance and proton pump inhibitors", Future Oncol, 1, pp.779~786 (2005)
91. Fais, S., "Evidence-based support for the use of proton pump inhibitors in cancer therapy", J. Transl. Med, 13, pp.368~ (2015)
92. Fais, S., "Targeting vacuolar H+-ATPases as a new strategy against cancer", Cancer Res, 67, pp.10627~10630 (2007)
93. Taylor, S., "Microenvironment acidity as a major determinant of tumor chemoresistance : Proton pump inhibitors(PPIs)as a novel therapeutic approach", Drug Resist. Updat, 23, pp.69~78 (2015)
94. Canitano, A., "Proton pump inhibitors induce a caspase-independent antitumor effect against human multiple myeloma", Cancer Lett, 376, pp.278~283 (2016)
95. Federici, C., "Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin", PLoS ONE, 9, pp.e88193~ (2014)
96. Luciani, F., "Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs", J. Natl Cancer Inst, 96, pp.1702~1713 (2004)
97. Dutta, D., "Search for inhibitors of endocytosis : intended specificity and unintended consequences", Cell. Logist, 2, pp.203~208 (2012)
98. Kirchhausen, T., "Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis", Methods Enzymol, 438, pp.77~93 (2008)
99. Gu, C., "Direct dynamin-actin interactions regulate the actin cytoskeleton", EMBO J, 29, pp.3593~3606 (2010)
100. Newton, A. J., "Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis", Proc. Natl Acad. Sci. USA, 103, pp.17955~17960 (2006)
101. Delmas, C., "The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft", Clin. Cancer Res, 9, pp.6062~6068 (2003)
102. Iraci, N., "Focus on extracellular vesicles : physiological role and signalling properties of extracellular membrane vesicles", Int. J. Mol. Sci, 17, pp.171~ (2016)
103. Zhang, H. G., "Exosomes : a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions", Am. J. Pathol, 184, pp.28~41 (2014)
104. Wang, M., "High throughput cell-based assay for identification of glycolate oxidase inhibitors as a potential treatment for primary hyperoxaluria type 1", Sci. Rep, 6, pp.34060~ (2016)
105. De Toro, J., "Emerging roles of exosomes in normal and pathological conditions : new insights for diagnosis and therapeutic applications", Front. Immunol, 6, pp.203~ (2015)
106. Salem, K. Z., "Exosomes in tumor angiogenesis", Methods Mol. Biol, 1464, pp.25~34 (2016)
107. Lobb, R. J., "Exosomes: key mediators of metastasis and pre-metastatic niche formation", Semin. Cell Dev. Biol, 67, pp.3~10 (2017)
108. Yu, J. L., "Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis", Blood, 105, pp.1734~1741 (2005)
109. Di Vizio, D., "Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease", Am. J. Pathol, 181, pp.1573~1584 (2012)
110. Chin, A. R., "Cancer-derived extracellular vesicles : the ‘soil conditioner’in breast cancer metastasis?", Cancer Metastasis Rev, 35, pp.669~676 (2016)
111. Isola, A. L., "Biology, therapy and implications of tumor exosomes in the progression of melanoma", Cancers, 8, pp.110~ (2016)
112. Allenson, K., "High prevalence of mutant KRAS in circulating exosomederived DNA from early-stage pancreatic cancer patients", Ann. Oncol, 28, pp.741~747 (2017)
113. Nuzhat, Z., "Tumour-derived exosomes as a signature of pancreatic cancer —liquid biopsies as indicators of tumour progression", Oncotarget, 8, pp.17279~17291 (2017)
114. Yang, Y., "Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth", Cell Res, 28, pp.862~864 (2018)
115. Shen, D. D., "LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer", Mol. Cancer, 21, pp.75~ (2022)
116. Shin, J. M., "Sulfisoxazole elicits robust antitumour immune response along with immune checkpoint therapy by inhibiting exosomal PD-L1", Adv. Sci, 9, pp.e2103245~ (2021)

관련 논문AI추천